Description
Semax is a synthetic heptapeptide based on a fragment of adrenocorticotropic hormone, commonly represented by the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its seven-amino-acid structure has made it a subject of laboratory investigation involving peptide signaling, neuronal pathways, gene-expression responses, and other biochemical processes.
Semax peptides are studied primarily in experimental systems focused on neurological and cellular signaling mechanisms. Semax peptide research may investigate pathways associated with neurotrophic signaling, oxidative processes, cellular stress responses, and molecular regulation within controlled laboratory models. Researchers also use Semax research to examine how this short peptide interacts with signaling systems without making assumptions about clinical effectiveness or human outcomes.
Features
- Composition: Synthetic heptapeptide
- Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
- Peptide Length: 7 amino acids
- Research Classification: ACTH-derived synthetic peptide
- Research Focus: Neuronal signaling, cellular stress responses, neurotrophic pathways, and gene-expression-related mechanisms
- Molecular Characteristic: Short linear peptide sequence
- Laboratory Application: Controlled biochemical and preclinical peptide studies
- Regulatory Research Context: FDA has identified Semax as a heptapeptide and has noted potential immunogenicity concerns associated with aggregation and peptide-related impurities in compounded preparations.
- Format: Supplied as lyophilized research material
- Recommended Storage: −20 °C unless otherwise specified in batch documentation
Disclaimer: Supplied strictly for laboratory research. Not intended for human or veterinary use, administration, consumption, diagnosis, treatment, or therapeutic purposes.
Reviews
There are no reviews yet.